{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T07:40:06Z","timestamp":1755934806014,"version":"3.44.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100001384","name":"Samuel Waxman Cancer Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001384","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.phymed.2025.157124","type":"journal-article","created":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T23:37:04Z","timestamp":1753832224000},"page":"157124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Rational combination of homoharringtonine to selectively target FLT3-ITD acute myeloid leukemia through synthetic lethality"],"prefix":"10.1016","volume":"146","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-8067-4664","authenticated-orcid":false,"given":"Ying","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxiao","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huimin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Chai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinghua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojing","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Waxman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7915-8593","authenticated-orcid":false,"given":"Yongkui","family":"Jing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11 Suppl","key":"10.1016\/j.phymed.2025.157124_bib0001","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1002\/(SICI)1097-0142(19971201)80:11+<2186::AID-CNCR4>3.0.CO;2-G","article-title":"Long-term survival of patients with acute myeloid leukemia: updated results from two trials evaluating postinduction chemotherapy","volume":"80","author":"Bloomfield","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.phymed.2025.157124_bib0002","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2024.286832","article-title":"Venetoclax combined with escalating doses of homoharringtonine, low-dose cytarabine, and granulocyte colony-stimulating factor demonstrates feasibility and tolerability for remission induction in pediatric acute myeloid leukemia","author":"Cheng","year":"2025","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.phymed.2025.157124_bib0003","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.molcel.2009.09.019","article-title":"Mislocalized activation of oncogenic RTKs switches downstream signaling outcomes","volume":"36","author":"Choudhary","year":"2009","journal-title":"Mol. Cell"},{"issue":"9","key":"10.1016\/j.phymed.2025.157124_bib0004","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/cdd.2009.83","article-title":"Bax activation by Bim?","volume":"16","author":"Czabotar","year":"2009","journal-title":"Cell Death. Differ."},{"issue":"1","key":"10.1016\/j.phymed.2025.157124_bib0005","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1182\/blood.V93.1.268","article-title":"Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system","volume":"93","author":"Dai","year":"1999","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.phymed.2025.157124_bib0006","doi-asserted-by":"crossref","first-page":"8482","DOI":"10.1002\/jcp.26786","article-title":"Mcl-1 targeting could be an intriguing perspective to cure cancer","volume":"233","author":"De Blasio","year":"2018","journal-title":"J. Cell Physiol."},{"issue":"3","key":"10.1016\/j.phymed.2025.157124_bib0007","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2174\/156800908784293640","article-title":"Deregulation of the mitochondrial apoptotic machinery and development of molecular targeted drugs in acute myeloid leukemia","volume":"8","author":"Del Poeta","year":"2008","journal-title":"Curr. Cancer Drug Targets."},{"issue":"8","key":"10.1016\/j.phymed.2025.157124_bib0008","doi-asserted-by":"crossref","first-page":"5963","DOI":"10.1021\/acs.jmedchem.3c01998","article-title":"Targeting myeloid leukemia-1 in cancer therapy: advances and directions","volume":"67","author":"Deng","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.phymed.2025.157124_bib0009","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2147\/OTT.S236740","article-title":"FMS-like tyrosine kinase 3 inhibitors in the treatment of acute myeloid leukemia: an update on the emerging evidence and safety profile","volume":"16","author":"Garciaz","year":"2023","journal-title":"Onco Targets. Ther."},{"issue":"4","key":"10.1016\/j.phymed.2025.157124_bib0010","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/00062752-200207000-00003","article-title":"Role of FLT3 in leukemia","volume":"9","author":"Gilliland","year":"2002","journal-title":"Curr. Opin. Hematol."},{"issue":"7","key":"10.1016\/j.phymed.2025.157124_bib0011","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S1470-2045(13)70152-9","article-title":"Homoharringtonine-based induction regimens for patients with de-novo acute myeloid leukaemia: a multicentre, open-label, randomised, controlled phase 3 trial","volume":"14","author":"Jin","year":"2013","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.phymed.2025.157124_bib0012","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/s40001-024-01856-x","article-title":"Homoharringtonine: updated insights into its efficacy in hematological malignancies, diverse cancers and other biomedical applications","volume":"29","author":"Khatua","year":"2024","journal-title":"Eur. J. Med. Res."},{"issue":"5","key":"10.1016\/j.phymed.2025.157124_bib0013","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1158\/1078-0432.CCR-15-1191","article-title":"Targeting of BCL2 Family proteins with ABT-199 and homoharringtonine reveals BCL2- and MCL1-dependent subgroups of diffuse large B-cell lymphoma","volume":"22","author":"Klanova","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"10","key":"10.1016\/j.phymed.2025.157124_bib0014","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1182\/blood-2018-03-828269","article-title":"BCL-2 inhibition in AML: an unexpected bonus?","volume":"132","author":"Konopleva","year":"2018","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.phymed.2025.157124_bib0015","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s12185-012-1123-9","article-title":"Molecular markers in acute myeloid leukaemia","volume":"96","author":"Kuhnl","year":"2012","journal-title":"Int. J. Hematol."},{"issue":"26","key":"10.1016\/j.phymed.2025.157124_bib0016","doi-asserted-by":"crossref","first-page":"6987","DOI":"10.1182\/blood-2011-03-340273","article-title":"FLT3\/ITD AML and the law of unintended consequences","volume":"117","author":"Levis","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.phymed.2025.157124_bib0017","doi-asserted-by":"crossref","first-page":"e409","DOI":"10.1038\/cddis.2012.149","article-title":"Translation inhibitors induce cell death by multiple mechanisms and Mcl-1 reduction is only a minor contributor","volume":"3","author":"Lindqvist","year":"2012","journal-title":"Cell Death. Dis."},{"issue":"17","key":"10.1016\/j.phymed.2025.157124_bib0018","doi-asserted-by":"crossref","first-page":"4440","DOI":"10.1158\/1078-0432.CCR-15-3057","article-title":"Binding of released bim to Mcl-1 is a mechanism of intrinsic resistance to ABT-199 which can be overcome by combination with daunorubicin or Cytarabine in AML cells","volume":"22","author":"Niu","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.phymed.2025.157124_bib0019","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1101\/gad.276725.115","article-title":"Inactivation of prosurvival bcl-2 proteins activates bax\/Bak through the outer mitochondrial membrane","volume":"30","author":"O'Neill","year":"2016","journal-title":"Genes Dev."},{"issue":"6","key":"10.1016\/j.phymed.2025.157124_bib0020","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.ccell.2017.11.003","article-title":"Synthetic lethality of combined bcl-2 inhibition and p53 activation in AML: mechanisms and superior antileukemic efficacy","volume":"32","author":"Pan","year":"2017","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.phymed.2025.157124_bib0021","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1182\/bloodadvances.2020003398","article-title":"Single-cell DNA sequencing reveals complex mechanisms of resistance to quizartinib","volume":"5","author":"Peretz","year":"2021","journal-title":"Blood Adv."},{"issue":"1","key":"10.1016\/j.phymed.2025.157124_bib0022","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41420-023-01317-0","article-title":"The GSK3beta\/Mcl-1 axis is regulated by both FLT3-ITD and Axl and determines the apoptosis induction abilities of FLT3-ITD inhibitors","volume":"9","author":"Qiu","year":"2023","journal-title":"Cell Death. Discov."},{"issue":"16","key":"10.1016\/j.phymed.2025.157124_bib0023","doi-asserted-by":"crossref","first-page":"4805","DOI":"10.1158\/1078-0432.CCR-16-1941","article-title":"Mitochondrial BAX determines the predisposition to apoptosis in Human AML","volume":"23","author":"Reichenbach","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.phymed.2025.157124_bib0024","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.ccell.2017.09.001","article-title":"Direct activation of BAX by BTSA1 overcomes apoptosis resistance in acute myeloid leukemia","volume":"32","author":"Reyna","year":"2017","journal-title":"Cancer Cell"},{"issue":"19","key":"10.1016\/j.phymed.2025.157124_bib0025","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.1038\/sj.onc.1207456","article-title":"FLT3 receptors with internal tandem duplications promote cell viability and proliferation by signaling through Foxo proteins","volume":"23","author":"Scheijen","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.phymed.2025.157124_bib0026","doi-asserted-by":"crossref","DOI":"10.1177\/2040620719827310","article-title":"Emerging treatment paradigms with FLT3 inhibitors in acute myeloid leukemia","volume":"10","author":"Short","year":"2019","journal-title":"Ther. Adv. Hematol."},{"issue":"10","key":"10.1016\/j.phymed.2025.157124_bib0027","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1038\/leu.2012.114","article-title":"Targeting the FMS-like tyrosine kinase 3 in acute myeloid leukemia","volume":"26","author":"Swords","year":"2012","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.phymed.2025.157124_bib0028","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1158\/1535-7163.MCT-05-0164","article-title":"Semisynthetic homoharringtonine induces apoptosis via inhibition of protein synthesis and triggers rapid myeloid cell leukemia-1 down-regulation in myeloid leukemia cells","volume":"5","author":"Tang","year":"2006","journal-title":"Mol. Cancer Ther."},{"issue":"12","key":"10.1016\/j.phymed.2025.157124_bib0029","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.tibs.2011.08.009","article-title":"BAX unleashed: the biochemical transformation of an inactive cytosolic monomer into a toxic mitochondrial pore","volume":"36","author":"Walensky","year":"2011","journal-title":"Trends. Biochem. Sci."},{"key":"10.1016\/j.phymed.2025.157124_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114538","article-title":"Homoharringtonine synergizes with quizartinib in FLT3-ITD acute myeloid leukemia by targeting FLT3-AKT-c-Myc pathway","volume":"188","author":"Wang","year":"2021","journal-title":"Biochem. Pharmacol."},{"issue":"9","key":"10.1016\/j.phymed.2025.157124_bib0031","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1158\/1535-7163.MCT-17-0298","article-title":"Arsenic trioxide and sorafenib induce synthetic lethality of FLT3-ITD acute myeloid leukemia cells","volume":"17","author":"Wang","year":"2018","journal-title":"Mol. Cancer Ther."},{"issue":"2","key":"10.1016\/j.phymed.2025.157124_bib0032","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/leu.2012.180","article-title":"Downregulation of Mcl-1 through GSK-3beta activation contributes to arsenic trioxide-induced apoptosis in acute myeloid leukemia cells","volume":"27","author":"Wang","year":"2013","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.phymed.2025.157124_bib0033","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1158\/1078-0432.CCR-15-0663","article-title":"Sorafenib inhibition of Mcl-1 accelerates ATRA-induced apoptosis in differentiation-responsive AML cells","volume":"22","author":"Wang","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.phymed.2025.157124_bib0034","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1200\/JCO.1985.3.5.617","article-title":"Homoharringtonine: an effective new drug for remission induction in refractory nonlymphoblastic leukemia","volume":"3","author":"Warrell","year":"1985","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.phymed.2025.157124_bib0035","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1124\/mol.110.068528","article-title":"Bcl-xL is a dominant antiapoptotic protein that inhibits homoharringtonine-induced apoptosis in leukemia cells","volume":"79","author":"Yin","year":"2011","journal-title":"Mol. Pharmacol."},{"issue":"7","key":"10.1016\/j.phymed.2025.157124_bib0036","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/s00432-024-05861-9","article-title":"Homoharringtonine may help improve the outcomes of venetoclax and azacitidine in AML1-ETO positive acute myeloid leukemia","volume":"150","author":"Yin","year":"2024","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.phymed.2025.157124_bib0037","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/17474086.2018.1420474","article-title":"A concise review of BCL-2 inhibition in acute myeloid leukemia","volume":"11","author":"Yogarajah","year":"2018","journal-title":"Expert. Rev. Hematol."},{"issue":"24","key":"10.1016\/j.phymed.2025.157124_bib0038","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.1182\/blood-2008-12-196055","article-title":"FLT3-ITD up-regulates MCL-1 to promote survival of stem cells in acute myeloid leukemia via FLT3-ITD-specific STAT5 activation","volume":"114","author":"Yoshimoto","year":"2009","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.phymed.2025.157124_bib0039","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1158\/1078-0432.CCR-24-1332","article-title":"Homoharringtonine added to venetoclax and azacitidine improves outcome and mitigates genetic impact in relapsed\/refractory AML: a multi-center cohort study","volume":"31","author":"Yu","year":"2024","journal-title":"Clin. Cancer Res."},{"issue":"43","key":"10.1016\/j.phymed.2025.157124_bib0040","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.1038\/onc.2009.240","article-title":"Proteasome inhibitors induce apoptosis in human lung cancer cells through a positive feedback mechanism and the subsequent Mcl-1 protein cleavage","volume":"28","author":"Yuan","year":"2009","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.phymed.2025.157124_bib0041","doi-asserted-by":"crossref","first-page":"490","DOI":"10.21037\/atm-22-1459","article-title":"Synergistic efficacy of homoharringtonine and venetoclax on acute myeloid leukemia cells and the underlying mechanisms","volume":"10","author":"Yuan","year":"2022","journal-title":"Ann. Transl. Med."},{"issue":"2","key":"10.1016\/j.phymed.2025.157124_bib0042","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/cncr.32534","article-title":"Sorafenib and omacetaxine mepesuccinate as a safe and effective treatment for acute myeloid leukemia carrying internal tandem duplication of fms-like tyrosine kinase 3","volume":"126","author":"Zhang","year":"2020","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.phymed.2025.157124_bib0043","first-page":"135","article-title":"[Toxicological studies of harrintonine and homoharringtonine (author's transl)]","volume":"14","author":"Zhang","year":"1979","journal-title":"Yao Xue Xue Bao"}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711325007639?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711325007639?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T07:09:53Z","timestamp":1755932993000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711325007639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":43,"alternative-id":["S0944711325007639"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2025.157124","relation":{},"ISSN":["0944-7113"],"issn-type":[{"type":"print","value":"0944-7113"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rational combination of homoharringtonine to selectively target FLT3-ITD acute myeloid leukemia through synthetic lethality","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2025.157124","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"157124"}}